Skip to main content

Table1 Clinical characteristics of pancreatic cancer patients in the multiple datasets

From: Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer

Variables

TCGA

ICGC

GSE21501

GSE62452

GSE71729

 

n = 167 (%)

n = 87 (%)

n = 98 (%)

n = 64 (%)

n = 123 (%)

Age

   < 65

77 (46.1)

35 (40.2)

NA

NA

NA

   ≥ 65

90 (53.9)

52 (59.8)

NA

NA

NA

Gender

  Female

76 (45.5)

41 (47.1)

NA

NA

NA

  Male

91 (54.5)

46 (52.9)

NA

NA

NA

Grade

  G1 − G2

118 (70.7)

54 (62.1)

NA

33 (51.6)

NA

  G3 − G4

49 (29.3)

33 (37.9)

NA

31 (48.4)

NA

Stage

  I − II

160 (95.8)

NA

NA

48 (75.0)

NA

  III − IV

7 (4.2)

NA

NA

16 (25.0)

NA

T

  T1 − T2

27 (16.2)

13 (14.9)

18 (18.4)

NA

NA

  T3 − T4

140 (83.8)

74 (85.1)

80 (81.6)

NA

NA

N

  N0/NX

49 (29.3)

28 (32.2)

12 (12.2)

NA

NA

  N1

118 (70.7)

59 (67.8)

86 (87.8)

NA

NA

Subtype

  Immunogenic

NA

22 (25.3)

NA

NA

NA

  ADEX

NA

14 (16.1)

NA

NA

NA

  Progenitor

NA

29 (33.3)

NA

NA

NA

  Squamous

NA

22 (25.3)

NA

NA

NA

  Classical

NA

NA

NA

NA

88 (71.5)

  Basal-like

NA

NA

NA

NA

35 (28.5)

Status

  Alive

76 (45.5)

32 (36.8)

35 (35.7)

15 (23.4)

40 (32.5)

  Dead

91 (54.5)

55 (63.2)

63 (64.3)

49 (76.6)

83 (67.5)

  1. TCGA The Cancer Genome Atlas, ICGC International Cancer Genome Consortium, ADEX Aberrantly Differentiated Endocrine Exocrine, NA not available